BioConsortia Appoints Dr. Damian Curtis as Senior Vice President of Research & Development

Industry Veteran Brings Nearly Two Decades of Biopharma and AgBio Leadership to Accelerate BioConsortia’s Microbial Genomics Platform

DAVIS, Calif.--(BUSINESS WIRE)--BioConsortia, Inc., a leader in agricultural technology specializing in advanced microbial solutions to enhance crop productivity and reduce agriculture’s ecological impact, today announced the appointment of Dr. Damian Curtis as Senior Vice President of Research & Development. Dr. Curtis succeeds Dr. Hong Zhu, who transitions to BioConsortia’s Strategic Advisory Board, where he will continue guiding the company’s long-term scientific strategy.

“Damian’s appointment reflects the exceptional caliber of scientific talent we have built at BioConsortia,” said Marcus Meadows-Smith, Chief Executive Officer. “Promoting from within demonstrates the strength of our R&D organization and our confidence in the scientific foundation that has made us a leader in agricultural microbial innovation. Damian combines deep expertise in microbiology, genomics, and gene editing with the strategic vision to translate cutting-edge science into commercially impactful agricultural products.”

A Career Built at the Intersection of Biology and Commercial Impact

Dr. Curtis brings nearly two decades of scientific leadership spanning biopharma and agricultural biology. He spent close to eight years at Bayer, where he developed deep expertise in microbial biology, genomics, and agricultural applications. Earlier in his career, he spent five years at Exelixis, broadening his capabilities in drug discovery, before transitioning to agricultural research. Damian played a key role at AgraQuest — the pioneering biocontrol company that achieved a successful exit through its acquisition by Bayer — where he gained formative experience in developing and commercializing biological crop protection products.

Since joining BioConsortia, Dr. Curtis has been central to advancing the company’s proprietary microbial discovery platform, strengthening capabilities in genome-informed strain selection, gene editing, trait optimization, and functional characterization. His focus on Gram-positive microorganisms — valued for their durability, formulation advantages, field stability, and consistent performance across diverse environments — aligns directly with BioConsortia’s strategic priorities.

“BioConsortia has assembled one of the most advanced microbial R&D organizations in agriculture,” said Dr. Curtis. “What differentiates this company is the integration of discovery biology, genomics, computational analytics, strain engineering, fermentation, formulation, and field development into a single innovation engine. I’m excited to expand our capabilities in microbial genomics and gene editing to develop next-generation biological solutions that deliver meaningful value to growers globally.”

Dr. Curtis’s appointment comes as BioConsortia advances a pipeline of seed treatment products targeting nitrogen efficiency, crop productivity, and sustainability outcomes across major global crops. The company’s heavy investment in genomic technologies and data-driven microbial characterization enables the rapid identification and optimization of elite microbial strains — spanning nitrogen-fixing, biocontrol, and biostimulant technologies designed to reduce dependence on synthetic agricultural inputs.

Dr. Hong Zhu Joins Strategic Advisory Board

During his tenure as SVP of R&D, Dr. Zhu was instrumental in building the scientific organization and innovation platform that define BioConsortia today — expanding capabilities across microbial discovery, product development, and translational science, while fostering a culture of scientific rigor and collaboration.

“Hong’s leadership established the company’s reputation for technical excellence and positioned us for our next chapter of growth,” said Meadows-Smith. “We are pleased that he will continue contributing as a strategic advisor.”

“I’m incredibly proud of what the BioConsortia R&D team has built,” said Dr. Zhu. “Damian is a highly respected scientific leader with the vision and expertise to take the organization forward. I look forward to supporting the company’s mission through my role on the advisory board.”

ABOUT BIOCONSORTIA

BioConsortia, Inc. is an agricultural biotechnology company specializing in advanced microbial solutions to enhance crop productivity and reduce agriculture’s ecological footprint. The company’s pipeline is focused predominantly on seed treatment products, including nitrogen-fixing, biocontrol, and biostimulant technologies targeting major global crops. For more information, visit www.bioconsortia.com.